- Home
- HKPD vs MBOT Comparison
HKPD vs MBOT Comparison
Compare HKPD & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HKPD
- MBOT
- Stock Information
- Founded
- HKPD 2016
- MBOT 2010
- Country
- HKPD Hong Kong
- MBOT United States
- Employees
- HKPD N/A
- MBOT N/A
- Industry
- HKPD Other Pharmaceuticals
- MBOT Medical/Dental Instruments
- Sector
- HKPD Health Care
- MBOT Health Care
- Exchange
- HKPD Nasdaq
- MBOT Nasdaq
- Market Cap
- HKPD 30.3M
- MBOT 32.7M
- IPO Year
- HKPD 2025
- MBOT N/A
- Fundamental
- Price
- HKPD N/A
- MBOT $1.96
- Analyst Decision
- HKPD
- MBOT Strong Buy
- Analyst Count
- HKPD 0
- MBOT 1
- Target Price
- HKPD N/A
- MBOT $7.00
- AVG Volume (30 Days)
- HKPD 555.0K
- MBOT 7.1M
- Earning Date
- HKPD 01-01-0001
- MBOT 11-13-2024
- Dividend Yield
- HKPD N/A
- MBOT N/A
- EPS Growth
- HKPD N/A
- MBOT N/A
- EPS
- HKPD 0.18
- MBOT N/A
- Revenue
- HKPD $16,688,364.00
- MBOT N/A
- Revenue This Year
- HKPD N/A
- MBOT N/A
- Revenue Next Year
- HKPD N/A
- MBOT N/A
- P/E Ratio
- HKPD $14.87
- MBOT N/A
- Revenue Growth
- HKPD 32.91
- MBOT N/A
- 52 Week Low
- HKPD $2.40
- MBOT $0.82
- 52 Week High
- HKPD $3.79
- MBOT $3.38
- Technical
- Relative Strength Index (RSI)
- HKPD N/A
- MBOT 59.30
- Support Level
- HKPD N/A
- MBOT $1.59
- Resistance Level
- HKPD N/A
- MBOT $2.39
- Average True Range (ATR)
- HKPD 0.00
- MBOT 0.44
- MACD
- HKPD 0.00
- MBOT -0.01
- Stochastic Oscillator
- HKPD 0.00
- MBOT 38.37
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The company's innovative platforms LIBERTY and Self-Cleaning Shunt (SCS) are in one of the fastest-growing segments in healthcare. The group continuously develops its technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen its product portfolio and create barriers of entry.